Alivus Life Sciences Q1 FY27 Earnings Call on July 31, 2026

Board & Shareholder Meetings View source PDF

ALIVUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+3.0%1-day move

₹1101.90

prior close

₹1107.50

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.2-0.2—-0.4+3.0+0.4————————

Up moveDown movePending

AI summary

Alivus Life Sciences Ltd (formerly Glenmark Life Sciences Ltd) has scheduled an earnings call to discuss its Q1 FY2026-27 financial performance on Friday, July 31, 2026, from 8:30 am to 9:30 am IST. The company has shared dial-in numbers for India and international participants from countries including the USA, UK, Singapore, Hong Kong, Japan, Australia, Canada, China, Italy, South Korea, and South Africa. Investor queries can be directed to Diwakar Pingle and Runjhun Jain at EY, with contact details provided.

Likely market impact

Routine disclosure. Investors can join to hear management discuss Q1 FY27 results, which may clarify business outlook and near-term performance.